Argus Research Maintains Buy on MetLife, Raises Price Target to $77
Portfolio Pulse from jenniferd'souza@benzinga.com
Argus Research analyst Kevin Heal maintains a 'Buy' rating on MetLife (NYSE:MET) and raises the price target from $70 to $77.
August 14, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Argus Research maintains a 'Buy' rating on MetLife and raises the price target from $70 to $77. This could potentially lead to an increase in MetLife's stock price.
The raised price target by Argus Research indicates a positive outlook for MetLife's stock. This could potentially attract more investors, leading to an increase in demand for the stock and subsequently, a rise in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100